BioAge Labs (BIOA) Other Working Capital Changes (2023 - 2026)
BioAge Labs' (BIOA) quarterly Other Working Capital Changes came in at $1.9 million in Q2 2026, up 146.1% year-over-year from $764314.3 in Q2 2025, and down 36.77% quarter-over-quarter from $3.0 million in Q1 2026.
Analysis
BioAge Labs (BIOA) Other Working Capital Changes (2023 - 2026) Analysis & Trends
BioAge Labs has disclosed Other Working Capital Changes across 4 years of filings, most recently posting $1.9 million for Q2 2026.
- In Q2 2026, Other Working Capital Changes rose 146.1% year-over-year to $1.9 million; the TTM figure through Jun 2026 stood at $1.0 million (down 87.34% YoY), while the FY2025 annual figure was -$6.7 million, down 153.97% from the prior year.
- Other Working Capital Changes came in at $1.9 million for Q2 2026 at BioAge Labs, down from $3.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $240000.0 in Q4 2024 to a low of -$25000.0 in Q3 2024.
- Average Other Working Capital Changes over 3 years is $27375.0, with a median of -$1500.0 recorded in 2025.
- Year-over-year, Other Working Capital Changes jumped 424.06% in 2024 and slumped 6786.96% in 2025.
- Over 4 years, Other Working Capital Changes stood at -$3.4 million in 2023, then jumped by 424.06% to $10.9 million in 2024, then sank by 121.26% to -$2.3 million in 2025, then soared by 181.5% to $1.9 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $1.9 million in Q2 2026, $3.0 million in Q1 2026, and -$2.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioAge Labs | 439.00 Mn | 439.00 Mn | -14.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Mn |
| Jun 30, 2026 | 1.88 Mn |
| Mar 31, 2026 | 2.98 Mn |
| Mar 31, 2026 | 2.98 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Sep 30, 2025 | -1.54 Mn |
| Sep 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | -4.08 Mn |
| Jun 30, 2025 | -4.08 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 10.86 Mn |
| Dec 31, 2024 | 10.86 Mn |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 684,000.00 |
| Jun 30, 2024 | 684,000.00 |
| Mar 31, 2024 | 937,000.00 |
| Mar 31, 2024 | 937,000.00 |